Serkan Yasar

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Journal: Future oncology (London, England)
Published: October 17, 2025

A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.

A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.

Journal: Journal of clinical medicine
Published: June 01, 2025

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel.

Journal: Medicina (Kaunas, Lithuania)
Published: May 04, 2025

"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Journal: Medicina (Kaunas, Lithuania)
Published: April 10, 2025

Prognostic value of the StAN score in elderly small cell lung cancer.

Prognostic value of the StAN score in elderly small cell lung cancer.

Journal: Scientific reports
Published: March 19, 2025

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Real-Life Experience with Entrectinib in Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Solid Tumors: A Multicenter Retrospective Trial.

Journal: Targeted oncology
Published: August 28, 2024

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer.

Journal: BMC cancer
Published: June 06, 2024

ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.

ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.

Journal: Annals of surgical oncology
Published: May 24, 2024

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study.

Journal: Annals of surgical oncology
Published: December 19, 2023

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

Journal: The oncologist
Published: August 04, 2023

Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.

Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.

Journal: Journal of cancer research and therapeutics
Published: April 03, 2023

Emerging treatment strategies in hepatobiliary cancer.

Emerging treatment strategies in hepatobiliary cancer.

Journal: Expert review of anticancer therapy
Published: February 21, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026